Unlock precision oncology insights with ddPCR™ technology

Discover how Droplet Digital^™ PCR is advancing precision monitoring in oncology through Development of a Highly Sensitive and Specific Droplet Digital PCR Assay for Multiplexed Detection and Longitudinal Monitoring of ESR1 Variants in Plasma: A QX600 Case Study, presented by Leisa Jackson, Scientist at Biodesix, and recorded earlier this year at ddPCR^™ World.

The following presentation is part of a Bio-Rad hosted event for Droplet Digital PCR (ddPCR) research applications. The products are intended for research use only and are not intended for use in diagnostic procedures. Any clinical applications, test validations, or performance claims discussed are the sole responsibility of the presenting institution or speaker and do not reflect the views or endorsements of Bio-Rad Laboratories.